| Patent Number |
Title Of Patent |
Date Issued |
| 7273995 |
Plasma generator |
September 25, 2007 |
| A microfabricated plasma generator and a method of generating a plasma, the plasma generator comprising: a substrate chip; a chamber defined by the substrate chip, the chamber including an inlet port through which analyte is in use delivered, an outlet port and a plasma-generation re |
| 7252814 |
Preparation of nanoparticles |
August 7, 2007 |
| The present invention provides a method and apparatus for the production of nanoparticles using a continuous flow miniaturised reaction vessel. In particular, the invention provides a method for preparing nanoparticles by a direct one-stage process. |
| 7081985 |
Optical wavelength shifting |
July 25, 2006 |
| An apparatus (8, 14) for wavelength shifting light from a first frequency .nu..sub.1 to a second frequency .nu..sub.2 is provided in the form of a semiconductor intersubband laser (8) lasing at its intersubband frequency .nu..sub.3. The output light is wavelength shifted to a frequency |
| 6908063 |
Vortex shedding and drag force reduction |
June 21, 2005 |
| Smoothly curved protuberances (8, 26, 34) are added to an elongate body (2, 16, 18, 20, 22, 32) to modify the fluid flow to reduce the drag Force F.sub.drag and the forces induced by vortex shedding F.sub.vortex. The protuberances can be arranged in diametrically opposed pairs with l |
| 6878751 |
Administration of resveratrol to treat inflammatory respiratory disorders |
April 12, 2005 |
| A method is provided for treating inflammatory respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The method involves administration, preferably oral or pulmonary administration, of an active agent selected from the group consisting of resveratrol, |
| 6838054 |
Biochemical devices and their methods of manufacture |
January 4, 2005 |
| Biochemical devices comprising a sensing surface that is at least partially covered by a nanocrystalline metal oxide semiconductor film which provides a recipient surface for immobilizing biochemical species on. The film has a mesoporous surface that gives up to a 1000 increase in bioche |
| 6685822 |
Process for the protection of reinforcement in reinforced concrete |
February 3, 2004 |
| The invention provides a reinforced concrete having improved corrosion resistance in which the content of voids in the concrete at the surface of the steel reinforcement is below 0.8%, preferably below 0.5%, more preferably below 0.2% by area of steel and in which there is a layer of |
| 6613210 |
Molecular imaging |
September 2, 2003 |
| A method of imaging molecules of interest within a biological sample includes shining a UV light onto the sample and detecting the molecular UV absorption. Where the molecules of interest are themselves UV absorbers, the intrinsic absorption of those molecules may be used. If the molecul |
| 6476312 |
Radiation concentrator for a photovoltaic device |
November 5, 2002 |
| Concentrator for use with photovoltaic devices includes a waveguide (2) incorporating quantum dots. The quantum dots red-shift the incident radiation to produce red-shifted radiation which is internally reflected within the waveguide (2). A photovoltaic device (10) converts the red-s |
| 6384193 |
Agents for the regulation of oestrogen synthesis |
May 7, 2002 |
| A system comprising a IL-6-IL-6sR complex and an agent that can block the interaction of the complex with gp130 to regulate oestrogen synthesis. |
| 6353317 |
Mesoscopic non-magnetic semiconductor magnetoresistive sensors fabricated with island lithograph |
March 5, 2002 |
| Mesoscopic magnetic field sensors which can detect weak magnetic fields (typically 0.05 Tesla) over areas as small as tens of thousands of square nanometers (e.g. 40 nm.times.400 nm). The combination of enhanced magneto-resistance in an inhomogeneous high mobility semiconductor, having |
| 6331330 |
Film or coating deposition and powder formation |
December 18, 2001 |
| Methods for depositing a material onto a substrate include the steps of: feeding a material solution including one or more precursor compounds, a solvent and a pH-modifying catalyst to an outlet to provide a stream of droplets of the material solution; generating an electric field to |
| 6274633 |
NMDA antagonist |
August 14, 2001 |
| The present invention relates to the use of xenon as an NMDA antagonist. In particular, the invention relates to a method of treatment comprising modulating the activity of an NMDA receptor in a mammal, the method comprising modulating the activity of the NMDA receptor by administering |
| 6180186 |
Fabrication method for fabricating an object as a plurality of successive laminae |
January 30, 2001 |
| A fabrication method in which an object is formed as a plurality of successive laminae, the method comprising the repeated steps of: (i) applying a precursor onto a recipient surface; and (ii) locally heating regions of the deposited precursor by directing a light beam onto those reg |
| 6103533 |
Molecular imaging |
August 15, 2000 |
| A method of identifying individual substances within a mixture of substances comprises causing the mixture to travel past a spaced series of detectors, each being arranged to produce a signal representative of a characteristic of the mixture as it passes, repeatedly measuring the sig |
| 6099840 |
Hepatitis B vaccine |
August 8, 2000 |
| A variant HBsAg protein of fragment thereof displaying the antigenicity of Hepatitis B virus surface antigen is disclosed, in which the variant protein or fragment thereof (vHBsAg) comprises a modified a determinant in which there is an amino acid other than glycine at position 145 of th |
| 6090550 |
Automated DNA sequencing comparing predicted and actual measurements |
July 18, 2000 |
| A method of automatically sequencing DNA comprises repeatedly determining the next base in the sequence as a function not only of a physical measurement made at that position, but also as a function of previously-determined near-by bases in the same sequence. Typically, a computer al |
| 6083741 |
Internalisation of DNA, using conjugates of poly-l-lysine and an integrin receptor ligand |
July 4, 2000 |
| Composition comprising DNA associated with a polycation moiety wherein the polycation moiety is itself coupled to an integrin receptor binding moiety is disclosed. Preferably, the integrin receptor binding moiety is a peptide, and the compositions can be used to deliver DNA to a cell whe |
| 6017435 |
Molecular imaging |
January 25, 2000 |
| A method of imaging molecules of interest within a biological sample includes shining a UV light onto the sample and detecting the molecular UV absorption. Where the molecules of interest are themselves UV absorbers, the intrinsic absorption of those molecules may be used. If the molecul |
| 5997629 |
Hazardous waste treatment |
December 7, 1999 |
| A method of solidifying a waste or soil composition containing at least one contaminant species which comprises adding to said composition binder and optionally water, mixing the binder into the waste or soil material to form a mixture thereof and simultaneously during formation of the m |
| 5891620 |
Steroid sulfatase assay |
April 6, 1999 |
| An assay comprising determining the absence or presence of steroid sulphatase activity is described. In a preferred embodiment, the assay uses white blood cells. The assay can be used to determine if an agent is an in vitro and/or in vivo steroid sulphatase inhibitor. |
| 5854024 |
Hepatitus B vaccine |
December 29, 1998 |
| A variant HBsAg protein of fragment thereof displaying the antigenicity of Hepatitis B virus surface antigen is disclosed, in which the variant protein or fragment thereof (vHBsAg) comprises a modified `a` determinant in which there is an amino acid other than glycine at position 145 of |
| 5851823 |
Hepatitis B vaccine |
December 22, 1998 |
| A variant HBsAg protein of fragment thereof displaying the antigenicity of Hepatitis B virus surface antigen is disclosed, in which the variant protein or fragment thereof (vHBsAg) comprises a modified `a` determinant in which there is an amino acid other than glycine at position 145 of |
| 5830886 |
Steroid sulphatase inhibitors |
November 3, 1998 |
| Steroid sulphatase inhibitors and pharmaceutical compositions containing them for use in the treatment of oestrone dependent tumors, especially breast cancer. The steroid sulphatase are sulphamate esters of formula (I): ##STR1## where R.sub.1 and R.sub.2 are each H, alkyl, alkeny |
| 5796498 |
Holographic imaging |
August 18, 1998 |
| A holographic imaging apparatus having a pulsed laser light source for generating an object beam and a reference beam whereby an object, obscured by a diffusing medium, is illuminated by the object beam. A real time interferogram recording medium is exposed to the coincidence of light |
| 5647018 |
Method and apparatus for generating images |
July 8, 1997 |
| A method of generating images of a specimen containing at least two regions of different opacity to the passage of radiation comprises irradiating the specimen with radiation from a radiation source, detecting the radiation to produce a plurality of signals indicative of the amplitude of |
| 5605692 |
Expression of structural (P1) region of 1 hepatitis A virus by vaccinia in cell culture for use |
February 25, 1997 |
| An isolated polypeptide comprising a substantially antigenic part of at least one hepatitis A virus epitope, the polypeptide being free from infectious material. The polypeptide is the expression product of a DNA molecule which has been incorporated into a virus, preferably vaccinia |
| 5520192 |
Apparatus for the monitoring and control of respiration |
May 28, 1996 |
| A respiration monitor for measuring the respiration of a subject on a mechanical ventilator comprises first transducer means arranged to produce a first signal representative of a respiration status of the subject, second transducer means arranged to produce a second signal representativ |
| 5496415 |
Concentrator solar cell having a multi-quantum well system in the depletion region of the cell |
March 5, 1996 |
| A solar cell formed from a semiconductor having a relative wide band-gap E.sub.b- characterized by a multi-quantum well system incorporated in the depletion region of the cell in which the quantum wells comprise regions of semiconductor with a smaller band gap separated by small amounts |
| 5429132 |
Probe system |
July 4, 1995 |
| A probe system for use in carrying out inspections in an enclosed, non-conducting environment, such as an endoscope for use in carrying out internal inspections of a human or animal patient, comprises sensing coils (7) mounted at spaced positions along the probe (6) for movement with the |
| 5344827 |
Steroid sulphatas inhibitors |
September 6, 1994 |
| Novel steroid 3-thiophosphonates are disclosed which are useful as steroid sulphatase inhibitors. |
| 5281587 |
Steroid sulphatase inhibitors |
January 25, 1994 |
| The present invention provides pharmaceutical preparations for the treatment of estrogen dependent tumors. The pharmaceutical preparations contain an effective amount of a steroid sulphatase inhibitor of the formula: ##STR1## where R is alkyl, preferably C.sub.1 -C.sub.6 alkyl, a |
